SouthState Corp’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $77.9K | Sell |
395
-31,466
| -99% | -$6.07M | ﹤0.01% | 408 |
|
|
2025
Q4 | $5.86M | Buy |
31,861
+1,138
| +4% | +$200K | 0.26% | 84 |
|
|
2025
Q3 | $4.71M | Sell |
30,723
-952
| -3% | -$144K | 0.22% | 95 |
|
|
2025
Q2 | $4.43M | Buy |
31,675
+12
| +0% | +$1.68K | 0.19% | 104 |
|
|
2025
Q1 | $4.65M | Buy |
31,663
+283
| +0.9% | +$40.9K | 0.21% | 99 |
|
|
2024
Q4 | $4.11M | Sell |
31,380
-994
| -3% | -$139K | 0.27% | 86 |
|
|
2024
Q3 | $5.04M | Buy |
32,374
+513
| +2% | +$82.8K | 0.35% | 72 |
|
|
2024
Q2 | $4.97M | Sell |
31,861
-134
| -0.4% | -$20.2K | 0.36% | 68 |
|
|
2024
Q1 | $4.34M | Buy |
31,995
+854
| +3% | +$113K | 0.34% | 77 |
|
|
2023
Q4 | $4.19M | Sell |
31,141
-113
| -0.4% | -$14.7K | 0.36% | 71 |
|
|
2023
Q3 | $4.23M | Sell |
31,254
-92
| -0.3% | -$12.6K | 0.4% | 63 |
|
|
2023
Q2 | $4.49M | Sell |
31,346
-252
| -0.8% | -$37.1K | 0.4% | 62 |
|
|
2023
Q1 | $4.39M | Sell |
31,598
-439
| -1% | -$59.1K | 0.4% | 64 |
|
|
2022
Q4 | $4.34M | Buy |
32,037
+262
| +0.8% | +$32.9K | 0.4% | 69 |
|
|
2022
Q3 | $3.48M | Sell |
31,775
-1,907
| -6% | -$242K | 0.35% | 71 |
|
|
2022
Q2 | $4.45M | Sell |
33,682
-2,029
| -6% | -$266K | 0.42% | 62 |
|
|
2022
Q1 | $4.74M | Buy |
35,711
+228
| +0.6% | +$27.3K | 0.38% | 68 |
|
|
2021
Q4 | $4.13M | Sell |
35,483
-1,599
| -4% | -$188K | 0.32% | 79 |
|
|
2021
Q3 | $4.45M | Buy |
37,082
+192
| +0.5% | +$22.4K | 0.37% | 71 |
|
|
2021
Q2 | $4.42M | Sell |
36,890
-784
| -2% | -$86K | 0.38% | 69 |
|
|
2021
Q1 | $3.75M | Sell |
37,674
-1,115
| -3% | -$112K | 0.35% | 73 |
|
|
2020
Q4 | $3.88M | Sell |
38,789
-2,444
| -6% | -$259K | 0.38% | 70 |
|
|
2020
Q3 | $4.52M | Buy |
41,233
+2,510
| +6% | +$279K | 0.47% | 59 |
|
|
2020
Q2 | $4.1M | Buy |
38,723
+6,006
| +18% | +$620K | 0.5% | 56 |
|
|
2020
Q1 | $2.92M | Buy |
32,717
+5,833
| +22% | +$549K | 0.43% | 63 |
|
|
2019
Q4 | $2.68M | Buy |
26,884
+2,052
| +8% | +$193K | 0.31% | 84 |
|
|
2019
Q3 | $2.21M | Sell |
24,832
-789
| -3% | -$68.4K | 0.28% | 87 |
|
|
2019
Q2 | $2.12M | Buy |
25,621
+144
| +0.6% | +$11.3K | 0.24% | 97 |
|
|
2019
Q1 | $2.06M | Buy |
25,477
+1,485
| +6% | +$117K | 0.21% | 101 |
|
|
2018
Q4 | $1.82M | Sell |
23,992
-27,539
| -53% | -$2.15M | 0.21% | 105 |
|
|
2018
Q3 | $4.08M | Buy |
51,531
+4,334
| +9% | +$328K | 0.42% | 81 |
|
|
2018
Q2 | $3.31M | Buy |
47,197
+14,403
| +44% | +$1.04M | 0.37% | 86 |
|
|
2018
Q1 | $2.29M | Buy |
+32,794
| New | +$2.27M | 0.26% | 100 |
|
Other funds holding AZN
IA
VCM
VAM
SouthState Corp's AZN Position: Q1 2026 in Review
SouthState Corp reduced its AstraZeneca (AZN) stake by 99% in Q1 2026, selling an estimated $6.07M and leaving 395 shares worth $77.9K. The position accounts for ﹤0.01% of the portfolio, ranked #408.
SouthState Corp first reported a position in AZN in Q1 2018 and has held it in 33 quarters since. The position peaked at $5.86M in Q4 2025. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- SouthState Corp held 395 shares of AstraZeneca worth $77.9K as of Q1 2026.
- SouthState Corp sold 31,466 AstraZeneca shares in Q1 2026, an estimated $6.07M.
- AstraZeneca made up ﹤0.01% of SouthState Corp's portfolio in Q1 2026, its #408 holding.
- SouthState Corp first reported a position in AstraZeneca in Q1 2018 and has held it in 33 quarters since.
- SouthState Corp's AstraZeneca position peaked at $5.86M in Q4 2025.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.